News + Publications
News
Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development
Series C – $12 Million
March 12, 2024
Read More
News
Siolta successfully doses first newborn in phase 2 study
Groundbreaking trial of STMC-103H for the prevention of atopic diseases
July 20, 2022
Read More
Publications
Microbial Genomics
Finding the right fit: evaluation of short-read and long-read sequencing approaches to maximize the utility of clinical microbiome data
Read More
News
Siolta Therapeutics awarded NIH grant funding
Advance Technology Small Business Innovation Grant Award from NIAID
February 9, 2022
Read More
News
Siolta Collaboration with Bio-Me
Microbiome-based Prognostics for Early Identification of Allergy and Asthma
November 23, 2020
Read More
News
Siolta Therapeutics closes financing round to support clinical development of lead program
Series B – $30 Million
September 22, 2020
Read More